FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Fujifilm New CT System Cleared

FDA clears a Fujifilm Healthcare Americas 510(k) for its new compact, 128-slice computed tomography (CT) system, the FCT iStream.

latest-news-card-1
FDA General

Public Citizen Ideas to Improve Advisory Committees

Public Citizen recommends three steps FDA should take to improve the public perception and understanding of the work of agency advisory committees.

latest-news-card-1
Human Drugs

14 Submissions with RWE in FY 2023: FDA

FDA publishes a table with information on 14 drug submissions in FY 2023 that contained real-world evidence.

Animal Drugs

PZAD Designation, Review Process Guidance

FDA publishes a guidance to help sponsors pursue Priority Zoonotic Animal Drug designation for a new animal drug.

latest-news-card-1
Human Drugs

Guidance on Study Underrepresentation Diversity Plans

FDA publishes a draft guidance on the content and format of certain diversity action plans intended to increase clinical study enrollment of participa...

latest-news-card-1
Human Drugs

Verona Gets Ohtuvayre Approval for COPD

FDA approves a Verona Pharma NDA for Ohtuvayre (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult p...

latest-news-card-1
Human Drugs

BrainStorm Gets FDA Alignment on CMC Issues

BrainStorm Cell Therapeutics says it has reached alignment with FDA on chemistry, manufacturing, and controls aspects of the companys upcoming Phase 3...

latest-news-card-1
Human Drugs

Sani-Care Salon Products CGMP Violations

FDA warns Cartersville, GA-based Sani-Care Salon Products about CGMP violations in its work as a contract manufacturer of finished drugs.

latest-news-card-1
Biologics

HCTP Violations at Indiana Lions Eye Bank

FDA warns the Carmel, IN-based Indiana Lions Eye Bank about deviations from the regulations for human cells, tissues, and cellular and tissue-based pr...

latest-news-card-1
Human Drugs

NDRP Modernization Successes Lead to Permanent Initiative

CDER Office of New Drugs Special Program Staff associate director Yoni Tyberg discusses the New Drug Regulatory Program modernization and its successe...